Founder/BOD
Hawthorne Effect, Inc.
Alamo, California, United States
Jodi Akin, Founder and CEO, Hawthorne Effect, Inc.
A healthcare executive, leader, innovator, advisor, and serial entrepreneur. Jodi has 30 years experience in clinical development, regulatory strategy, management, and medtech market development from start-ups to S&P 500 companies. Prior to Hawthorne Effect, Inc., Jodi was Global VP Clinical Affairs at Edwards Lifesciences, LLC, where she led the seminal clinical trials and regulatory approvals for transcatheter heart valve therapy. Also a humanitarian, Jodi led international healthcare initiatives including Heart To Heart International, The Nahapetov Friendship Foundation and the China Heart Group, a joint venture with the United Nations Industrial Development Organization. She holds an undergraduate degree in Foreign Service from Georgetown University, Masters in Physiology and Nursing from Pace University and 8 patents with a few more pending.
Disclosure information not submitted.
Community-Based Complex Clinical Trials
Monday, March 10, 2025
11:22 AM – 11:30 AM ET
Monday, March 10, 2025
12:10 PM – 12:20 PM ET
HARNESSING BIG DATA AND DIGITAL HEALTH TO TRANSFORM CLINICAL TRIALS
Tuesday, March 11, 2025
10:50 AM – 12:00 PM ET
Evolving Clinical Trial Strategies and Platforms
Tuesday, March 11, 2025
11:06 AM – 11:14 AM ET
Panel Discussion | Digital Heath Apps in Clinical Trials: Ready for Prime Time?
Tuesday, March 11, 2025
11:30 AM – 12:00 PM ET